SG Americas Securities’s Pulmonx LUNG Stock Holding History
Bought
Maintained
Sold
Other funds holding LUNG
SCM
ECM
SG Americas Securities's LUNG Position: Q1 2026 in Review
SG Americas Securities sold out of Pulmonx (LUNG) in Q1 2026, closing a stake of 10,747 shares — an estimated $24K sold.
SG Americas Securities first reported a position in LUNG in Q3 2021 and held it in 12 quarters. The position peaked at $435K in Q2 2022. 114 funds tracked by Wall St. Rank hold LUNG as of Q1 2026.
- SG Americas Securities reported no remaining Pulmonx position as of Q1 2026 after selling out during the quarter.
- SG Americas Securities sold 10,747 Pulmonx shares in Q1 2026, an estimated $24K.
- SG Americas Securities first reported a position in Pulmonx in Q3 2021 and held it in 12 quarters.
- SG Americas Securities's Pulmonx position peaked at $435K in Q2 2022.
- 114 funds tracked by Wall St. Rank held Pulmonx as of Q1 2026.
Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.